ge Y administered exogenous rCX3CL1 to mice with cerebral ischemia-reperfusion and found that rCX3CL1 could inhibit CX3CL1 signaling pathway can be used as a therapeutic target to promote functional recovery after stroke (Ge et al., 2022). This evidence concerns the gene CX3CL1 and stroke disorder.